BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11223760)

  • 1. Outpatient treatment of deep venous thrombosis: a clinical care pathway managed by the emergency department.
    Vinson DR; Berman DA
    Ann Emerg Med; 2001 Mar; 37(3):251-8. PubMed ID: 11223760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient management of deep venous thrombosis: 2 models of integrated care.
    Vinson DR; Berman DR; Patel PB; Hickey DO
    Am J Manag Care; 2006 Jul; 12(7):405-10. PubMed ID: 16834527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism.
    Grau E; Tenias JM; Real E; Medrano J; Ferrer R; Pastor E; Selfa S
    Am J Hematol; 2001 May; 67(1):10-4. PubMed ID: 11279651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protocol for ambulant treatment of deep venous thrombosis in a leg: efficacious and safe in general practice].
    van Hulsteijn LH; Brenninkmeijer BJ; Trügg RA; Litjens-van de Ven AJ; Huisman MV
    Ned Tijdschr Geneeskd; 2000 Mar; 144(12):557-60. PubMed ID: 10746047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins.
    Siragusa S; Anastasio R; Porta C; Falaschi F; Pirrelli S; Palmieri P; Gamba G; Granzow K; Malato A; Minardi V; Tatoni P; Bressan MA; Mariani G
    Arch Intern Med; 2004 Dec 13-27; 164(22):2477-82. PubMed ID: 15596639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
    Ramacciotti E; Araújo GR; Lastoria S; Maffei FH; Karaoglan de Moura L; Michaelis W; Sandri JL; Dietrich-Neto F;
    Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.
    Wells PS; Forgie MA; Simms M; Greene A; Touchie D; Lewis G; Anderson J; Rodger MA
    Arch Intern Med; 2003 Apr; 163(8):917-20. PubMed ID: 12719200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group.
    van den Belt AG; Bossuyt PM; Prins MH; Gallus AS; Büller HR
    Thromb Haemost; 1998 Feb; 79(2):259-63. PubMed ID: 9493572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient use of low molecular weight heparin (Dalteparin) for the treatment of deep vein thrombosis of the upper extremity.
    Savage KJ; Wells PS; Schulz V; Goudie D; Morrow B; Cruickshank M; Kovacs MJ
    Thromb Haemost; 1999 Sep; 82(3):1008-10. PubMed ID: 10494754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of deep venous thrombosis at home: evolution from ideas to medical practice].
    Boccalon H; Elias A; Chalé JJ; Cadene A; Dumoulin A
    Bull Acad Natl Med; 1998; 182(1):101-12; discussion 112-5. PubMed ID: 9622936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Outpatient treatment of deep vein thrombosis with low-molecular-weight heparins. Experience from an open, prospective study in daily practice].
    Heidenreich C; Hohmann V; Bramlage P
    Med Klin (Munich); 2009 Jan; 104(1):20-7. PubMed ID: 19142593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost savings and effectiveness of outpatient treatment with low molecular weight heparin of deep vein thrombosis in a community hospital.
    Lee M; Pao D; Hsu T; Sonderskov A
    Can J Clin Pharmacol; 2004; 11(1):e17-27. PubMed ID: 15226523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of ambulatory and inpatient treatment of acute deep venous thrombosis of the leg: subjective and economic aspects].
    Frank D; Blättler W
    Schweiz Med Wochenschr; 1998 Sep; 128(36):1328-33. PubMed ID: 9784675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An outpatient program to treat deep venous thrombosis with low-molecular-weight heparin.
    Pearson SD; Blair R; Halpert A; Eddy E; Mckean S
    Eff Clin Pract; 1999; 2(5):210-7. PubMed ID: 10623053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy.
    Rodger MA; Gagné-Rodger C; Howley HE; Carrier M; Coyle D; Wells PS
    Thromb Res; 2003; 112(1-2):13-8. PubMed ID: 15013267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparin, bemiparin, in the outpatient treatment and secondary prophylaxis of venous thromboembolism in standard clinical practice: the ESFERA Study.
    Santamaría A; Juárez S; Reche A; Gómez-Outes A; Martínez-González J; Fontcuberta J;
    Int J Clin Pract; 2006 May; 60(5):518-25. PubMed ID: 16700847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
    Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
    Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.